Methotrexate for recurrent chronic rhinosinusitis with nasal polyps: A randomized controlled phase II clinical trial
ConclusionLow-dose MTX was a safe and effective maintenance therapy for patients with recurrent postoperative CRSwNP.This article is protected by copyright. All rights reserved
Source: International Forum of Allergy and Rhinology - Category: Allergy & Immunology Authors: Asli CAKIR CETIN,
Yesim TUNCOK,
Pembe KESKINOGLU,
Mualla Aylin ARICI,
Fatos ONEN,
Mustafa Cenk ECEVIT Tags: ORIGINAL ARTICLE Source Type: research
More News: Allergy | Allergy & Immunology | Clinical Trials | Corticosteroid Therapy | Methotrexate | Methylprednisolone | Mometasone | Nasonex | Polyps | Turkey Health